Status:

ACTIVE_NOT_RECRUITING

LIBRE (Ligamys, Internal Bracing, REconstruction) Study: Comparing Three Surgery Techniques After an Acute ACL Rupture.

Lead Sponsor:

University Hospital, Antwerp

Collaborating Sponsors:

Universitair Ziekenhuis Brussel

Onze Lieve Vrouw Hospital

Conditions:

Anterior Cruciate Ligament Rupture

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

Single-blind, multi-centre, prospective, randomized controlled trial comparing Ligamys Anterior Cruciate Ligament (ACL) repair, Internal Bracing ACL repair and conventional ACL reconstruction for rela...

Detailed Description

Rationale The conventional operative treatment of an anterior cruciate ligament (ACL) rupture is an ACL reconstruction, whereby the residual ruptured ACL is removed and replaced by an autograft hamstr...

Eligibility Criteria

Inclusion

  • • Primary acute proximal ACL rupture (MRI and per-operative confirmation): 3-digit ACL rupture classification, type A (supplement 1)
  • Between 18-50 years, male or female
  • Randomization and surgery within 4 weeks after the ACL rupture (Study 1)
  • Randomization and surgery between 5-12 weeks after the ACL rupture (Study 2)
  • The ACL remnant is suitable for repair in the three treatment groups: the distal ACL remnant must be in contact with the proximal remnant/femoral condyle for at least 75% (per-operative confirmation)
  • The patient is mentally and verbally capable of participating in the study.
  • Written informed consent (according to the International Conference on Harmonisation (ICH)-GCP Guidelines).

Exclusion

  • • Known posterior cruciate ligament (PCL) and/or posterolateral ligamentous complex (PLC), lateral collateral ligament (LCL) or medial collateral ligament (MCL) grade 3 injury.
  • Known osseous fractures that could impair revalidation and/or ACL repair
  • Patients with neurological disorders or systemic diseases
  • Patients with trauma/fractures in the lower limb in the past 6 months that could influence rehabilitation
  • Non-sportive patients with a Tegner score of \<3: these patients could probably counteract instability complaints with intensive physiotherapy.
  • Any inflammatory disease, Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), active malignancy
  • Patient not suited for intervention due to lack of mobility, meaning not achieving 90° of flexion before surgery.

Key Trial Info

Start Date :

February 15 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 30 2025

Estimated Enrollment :

95 Patients enrolled

Trial Details

Trial ID

NCT03441295

Start Date

February 15 2018

End Date

August 30 2025

Last Update

May 16 2024

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

University Hospital, Antwerp

Edegem, Antwerp, Belgium, 2650

2

University Hospital, Brussels

Jette, Brussels Capital, Belgium, 1090

3

OLV Hospital

Aalst, Oost-Vlaanderen, Belgium, 9300